Denali Advisors LLC Buys New Holdings in Ardent Health, Inc. $ARDT

Denali Advisors LLC purchased a new position in shares of Ardent Health, Inc. (NYSE:ARDT) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 184,800 shares of the company’s stock, valued at approximately $2,449,000.

Other hedge funds have also recently added to or reduced their stakes in the company. CWM LLC increased its holdings in shares of Ardent Health by 990.6% during the second quarter. CWM LLC now owns 2,203 shares of the company’s stock valued at $30,000 after acquiring an additional 2,001 shares in the last quarter. KLP Kapitalforvaltning AS bought a new position in shares of Ardent Health in the 3rd quarter worth $80,000. New York State Common Retirement Fund grew its position in Ardent Health by 121.4% in the 2nd quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock valued at $85,000 after purchasing an additional 3,400 shares during the period. State of Alaska Department of Revenue bought a new stake in Ardent Health during the 3rd quarter valued at $103,000. Finally, Wealth Enhancement Advisory Services LLC acquired a new position in Ardent Health during the third quarter worth $155,000.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the stock. Truist Financial reduced their price objective on shares of Ardent Health from $21.00 to $13.00 and set a “buy” rating for the company in a report on Friday, November 14th. Wall Street Zen cut shares of Ardent Health from a “buy” rating to a “hold” rating in a research report on Sunday, November 23rd. Mizuho decreased their price objective on Ardent Health from $20.00 to $12.00 and set an “outperform” rating for the company in a report on Thursday, December 18th. Leerink Partners set a $16.00 price objective on Ardent Health in a research note on Friday, November 14th. Finally, Stephens dropped their target price on Ardent Health from $21.00 to $17.00 and set an “overweight” rating on the stock in a report on Friday, November 14th. Six investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, Ardent Health has a consensus rating of “Hold” and a consensus price target of $14.58.

Ardent Health Price Performance

Ardent Health stock opened at $9.59 on Monday. Ardent Health, Inc. has a 52 week low of $8.07 and a 52 week high of $15.59. The company’s 50 day moving average price is $8.79 and its two-hundred day moving average price is $11.21. The stock has a market cap of $1.37 billion, a P/E ratio of 6.61, a P/E/G ratio of 5.56 and a beta of 0.72. The company has a quick ratio of 1.95, a current ratio of 2.08 and a debt-to-equity ratio of 0.67.

Key Headlines Impacting Ardent Health

Here are the key news stories impacting Ardent Health this week:

• Neutral Sentiment: Brokerage consensus: analysts give ARDT an average recommendation of “Hold,” suggesting no strong near-term analyst-driven buying momentum. Ardent Health Hold Recommendation
• Neutral Sentiment: Earnings calendar: Ardent will report Q4 and full‑year 2025 results after the close on March 4, 2026, with a conference call March 5 — a near-term catalyst that could clarify the impact of receivable reserves and any write-offs. Earnings Release & Call
• Negative Sentiment: Litigation over reserve accounting and alleged misstatements: multiple law firms have filed or are soliciting lead plaintiffs in securities class actions alleging Ardent misled investors about receivable valuation (the contested “180‑day cliff”) and disclosure of potential write-offs (~$97M cited by some notices). The flurry of filings/solicitations (Hagens Berman, BFA Law, Schall, Levi & Korsinsky, Rosen, Pomerantz, Faruqi, and others) creates legal and uncertainty risk; March 9, 2026 is repeatedly listed as the lead‑plaintiff deadline. BFA Law Class Action Notice Hagens Berman Investigation Schall Law Firm Notice

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.